Vancouver-based Forbes Medi-Tech has signed an international supply agreement with Australian firm Pan Pharmaceuticals for Reducol, a cholesterol-lowering phytosterol-based ingredient. The initial supply agreement is for a minimum of three-years, and secures Sydney-based Pan Pharmaceuticals' exclusive rights to supply Reducol in the form of a dietary supplement to the Australian market, and selected countries in Asia, the Middle East, Africa, as well as three countries in Europe.